Clinical trial
Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer
NCT00512668
Study timeline
Study start (unknown)2007-09-01Date precision: month
Registry last updated2013-01-07
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Adenocarcinoma of the Prostateunresolved
Recurrent Prostate Cancerunresolved
Interventions
leuprolide acetateDRUG · verified · RxNorm: leuprolide acetate
goserelin acetateDRUG · verified · RxNorm: goserelin acetate
bicalutamideDRUG · verified · RxNorm: bicalutamide
nilutamideDRUG · verified · RxNorm: nilutamide
flutamideDRUG · verified · RxNorm: flutamide
temsirolimusDRUG · verified · RxNorm: temsirolimus
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00512668 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.